| Anidulafungin versus fluconazole for invasive candidiasis AC Reboli, C Rotstein, PG Pappas, SW Chapman, DH Kett, D Kumar, ... New England Journal of Medicine 356 (24), 2472-2482, 2007 | 1044 | 2007 |
| Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant AC Steere, VK Sikand, F Meurice, DL Parenti, E Fikrig, RT Schoen, ... New England Journal of Medicine 339 (4), 209-215, 1998 | 879 | 1998 |
| Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections LE Jauregui, S Babazadeh, E Seltzer, L Goldberg, D Krievins, M Frederick, ... Clinical infectious diseases 41 (10), 1407-1415, 2005 | 374 | 2005 |
| Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease EB Keeffe, S Iwarson, BJ McMahon, KL Lindsay, RS Koff, M Manns, ... Hepatology 27 (3), 881-886, 1998 | 350 | 1998 |
| A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis DS Krause, AE Simjee, C Van Rensburg, J Viljoen, TJ Walsh, ... Clinical infectious diseases 39 (6), 770-775, 2004 | 284 | 2004 |
| Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal JA Dowell, W Knebel, T Ludden, M Stogniew, D Krause, T Henkel The Journal of Clinical Pharmacology 44 (6), 590-598, 2004 | 208 | 2004 |
| Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia DS Krause, J Reinhardt, JA Vazquez, A Reboli, BP Goldstein, M Wible, ... Antimicrobial agents and chemotherapy 48 (6), 2021-2024, 2004 | 208 | 2004 |
| A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial N Binkley, M Bolognese, A Sidorowicz‐Bialynicka, T Vally, R Trout, ... Journal of bone and mineral research 27 (8), 1821-1829, 2012 | 164 | 2012 |
| Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment JA Dowell, M Stogniew, D Krause, B Damle The Journal of Clinical Pharmacology 47 (4), 461-470, 2007 | 139 | 2007 |
| Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine JA Dowell, M Stogniew, D Krause, T Henkel, IE Weston The Journal of Clinical Pharmacology 45 (2), 227-233, 2005 | 132 | 2005 |
| Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults BJ McMahon, J Williams, L Bulkow, M Snowball, R Wainwright, ... Journal of infectious diseases 171 (3), 676-679, 1995 | 118 | 1995 |
| Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants GW Letson, CN Shapiro, D Kuehn, C Gardea, TK Welty, DS Krause, ... The Journal of pediatrics 144 (3), 327-332, 2004 | 99 | 2004 |
| Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children KB Balcarek, M Regina Bagley, RF Pass, ER Schiff, DS Krause Journal of Infectious Diseases 171 (Supplement_1), S70-S72, 1995 | 88 | 1995 |
| Lack of pharmacokinetic interaction between anidulafungin and tacrolimus JA Dowell, M Stogniew, D Krause, T Henkel, B Damle The Journal of Clinical Pharmacology 47 (3), 305-314, 2007 | 82 | 2007 |
| Does salmon calcitonin cause cancer? A review and meta-analysis G Wells, J Chernoff, JP Gilligan, DS Krause Osteoporosis International 27 (1), 13-19, 2016 | 80 | 2016 |
| Hepatitis B vaccine administered to children and adolescents at yearly intervals NA Halsey, LH Moulton, JC O'Donovan, JR Walcher, ML Thoms, ... Pediatrics 103 (6), 1243-1247, 1999 | 74 | 1999 |
| Safety and immunogenicity of an outer surface protein A vaccine in subjects with previous Lyme disease RT Schoen, F Meurice, CM Brunet, S Cretella, DS Krause, JE Craft, ... Journal of Infectious Diseases 172 (5), 1324-1329, 1995 | 70 | 1995 |
| Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates J Goldfarb, J BALEY, SV MEDENDORP, D SETO, H GARCIA, P TOY, ... The Pediatric infectious disease journal 13 (1), 18-21, 1994 | 65 | 1994 |
| Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents GM Schiff, JR Sherwood, JB Zeldis, DS Krause Journal of adolescent health 16 (1), 12-17, 1995 | 62 | 1995 |
| Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules CL Troisi, FB Hollinger, DS Krause, LK Pickering Vaccine 15 (15), 1613-1617, 1997 | 60 | 1997 |
